DCTN5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.947600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.399200E-01
Normal-vs-Stage2
3.435600E-01
Normal-vs-Stage3
9.028400E-01
Normal-vs-Stage4
1.365170E-01
Stage1-vs-Stage2
7.674200E-01
Stage1-vs-Stage3
3.012800E-01
Stage1-vs-Stage4
6.879000E-01
Stage2-vs-Stage3
2.065000E-01
Stage2-vs-Stage4
4.556600E-01
Stage3-vs-Stage4
1.835780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.237000E-01
Normal-vs-AfricanAmerican
3.604200E-01
Normal-vs-Asian
3.125200E-01
Caucasian-vs-AfricanAmerican
9.067800E-01
Caucasian-vs-Asian
7.552600E-01
AfricanAmerican-vs-Asian
7.223200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.199600E-01
Normal-vs-Female
5.151600E-01
Male-vs-Female
1.833580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.432400E-01
Normal-vs-Age(41-60Yrs)
3.104800E-01
Normal-vs-Age(61-80Yrs)
4.755600E-01
Normal-vs-Age(81-100Yrs)
2.012800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.906000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.060200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.856800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.114600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.530600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.019800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.413000E-01
Normal-vs-Daily Drinker
4.712600E-01
Normal-vs-Weekly Drinker
2.918200E-01
Normal-vs-Occasional Drinker
4.879000E-01
Normal-vs-Social Drinker
1.922240E-01
Non Drinker-vs-Daily Drinker
6.170400E-01
Non Drinker-vs-Weekly Drinker
2.984400E-01
Non Drinker-vs-Occasional Drinker
9.091800E-01
Non Drinker-vs-Social Drinker
5.476400E-01
Daily Drinker-vs-Weekly Drinker
6.203200E-01
Daily Drinker-vs-Occasional Drinker
7.278600E-01
Daily Drinker-vs-Social Drinker
9.541800E-01
Weekly Drinker-vs-Occasional Drinker
3.805000E-01
Weekly Drinker-vs-Social Drinker
5.869600E-01
Occasional Drinker-vs-Social Drinker
6.292000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.668980E-01
Normal-vs-Grade 2
3.124300E-02
Normal-vs-Grade 3
1.135990E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.760200E-04
Grade 1-vs-Grade 3
6.05240000000062E-05
Grade 1-vs-Grade 4
1.668980E-01
Grade 2-vs-Grade 3
5.854600E-01
Grade 2-vs-Grade 4
3.124300E-02
Grade 3-vs-Grade 4
1.135990E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.541400E-01
Normal-vs-NonDiabetic
3.826200E-01
Diabetic-vs-NonDiabetic
5.070400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.368500E-02
Normal-vs-NoPancreatitis
4.513600E-01
Pancreatitis-vs-NoPancreatitis
4.027800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.306800E-01
Normal-vs-N1
3.888800E-01
N0-vs-N1
8.704200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.359030E-01
Normal-vs-TP53-NonMutant
7.686200E-01
TP53-Mutant-vs-TP53-NonMutant
3.803700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
